chr12-115970706-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_015335.5(MED13L):c.5955C>T(p.Leu1985Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,614,102 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0079   (  24   hom.,  cov: 32) 
 Exomes 𝑓:  0.00078   (  10   hom.  ) 
Consequence
 MED13L
NM_015335.5 synonymous
NM_015335.5 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.338  
Publications
1 publications found 
Genes affected
 MED13L  (HGNC:22962):  (mediator complex subunit 13L) The protein encoded by this gene is a subunit of the Mediator complex, a large complex of proteins that functions as a transcriptional coactivator for most RNA polymerase II-transcribed genes. The encoded protein is involved in early development of the heart and brain. Defects in this gene are a cause of transposition of the great arteries, dextro-looped (DTGA).[provided by RefSeq, Jul 2010] 
MED13L Gene-Disease associations (from GenCC):
- cardiac anomalies - developmental delay - facial dysmorphism syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Labcorp Genetics (formerly Invitae), G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71). 
BP6
Variant 12-115970706-G-A is Benign according to our data. Variant chr12-115970706-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.338 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00794 (1209/152324) while in subpopulation AFR AF = 0.0274 (1140/41562). AF 95% confidence interval is 0.0261. There are 24 homozygotes in GnomAd4. There are 556 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High AC in GnomAd4 at 1209 AD gene. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00792  AC: 1205AN: 152206Hom.:  24  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1205
AN: 
152206
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00192  AC: 481AN: 251134 AF XY:  0.00143   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
481
AN: 
251134
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000776  AC: 1135AN: 1461778Hom.:  10  Cov.: 31 AF XY:  0.000659  AC XY: 479AN XY: 727190 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1135
AN: 
1461778
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
479
AN XY: 
727190
show subpopulations 
African (AFR) 
 AF: 
AC: 
893
AN: 
33474
American (AMR) 
 AF: 
AC: 
71
AN: 
44706
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39694
South Asian (SAS) 
 AF: 
AC: 
5
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53414
Middle Eastern (MID) 
 AF: 
AC: 
15
AN: 
5760
European-Non Finnish (NFE) 
 AF: 
AC: 
34
AN: 
1111942
Other (OTH) 
 AF: 
AC: 
117
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.463 
Heterozygous variant carriers
 0 
 65 
 130 
 194 
 259 
 324 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 30 
 60 
 90 
 120 
 150 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00794  AC: 1209AN: 152324Hom.:  24  Cov.: 32 AF XY:  0.00746  AC XY: 556AN XY: 74490 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1209
AN: 
152324
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
556
AN XY: 
74490
show subpopulations 
African (AFR) 
 AF: 
AC: 
1140
AN: 
41562
American (AMR) 
 AF: 
AC: 
53
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
68032
Other (OTH) 
 AF: 
AC: 
11
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 53 
 107 
 160 
 214 
 267 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
11
AN: 
3476
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 17, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Transposition of the great arteries, dextro-looped    Benign:1 
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.